Hypertension: a new perspective in therapy and metabolic effect. Part I.
Bol Asoc Med P R
; 83(9): 399-401, 1991 Sep.
Article
en En
| MEDLINE
| ID: mdl-1807274
Antihypertensive Therapy has been ineffective in reducing the incidence of coronary artery disease. It has been suggested that the metabolic and biochemical alterations induced by some antihypertensive drugs may be responsible for their failure to reduce cardiovascular mortality in patients with hypertension. Hypertension is only one of multiple coronary risk factors associated to insulin resistance. This cluster of risk factors is call "The Syndrome of Insulin Resistance" by some and "Syndrome X" by Reaven and others. Is important to know this information when pharmacological antihypertensive therapy is contemplated.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Resistencia a la Insulina
/
Hipertensión
/
Antihipertensivos
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Bol Asoc Med P R
Año:
1991
Tipo del documento:
Article
Pais de publicación:
Puerto Rico